CONFIDENTIAL SERVICES AGREEMENTServices Agreement • August 7th, 2015 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • New York
This Services Agreement (the “Agreement”) dated as of June 11, 2015 (the “Effective Date”) is between IMMUNOCELLULAR THERAPEUTICS, LTD., a Delaware limited liability company having its principal office at 23622 Calabasas Road, Suite 300, Calabasas, CA 91302 (the “Client”) and PCT, LLC, A CALADRIUS COMPANY, a Delaware limited liability company having its principal office at 4 Pearl Court, Suite C, Allendale, New Jersey 07401 (“PCT”), each a “Party” and collectively the “Parties”. This Agreement incorporates by reference the terms and conditions set forth in Attachment A (“Attachment A”) and Attachment B (“Attachment B”) each attached hereto and made a part hereof. Capitalized terms not otherwise defined herein will have the meaning set forth in Attachment A or Attachment B, as applicable. In consideration of the premises and mutual covenants herein contained, the Parties hereby agree as follows:
CONFIDENTIAL AMENDED & RESTATED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 7th, 2015 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • California
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
